Apocard,
Flécaïne,
Flecadura,
Flecainid Isis,
Flecainid-Isis,
Flecainide,
Flecainide Acetate,
Flecainide Monoacetate,
Flecainide Monoacetate, (+-)-Isomer,
Flecainide Monoacetate, (R)-Isomer,
Flecainide Monoacetate, (S)-Isomer,
Flecainide, (R)-Isomer,
Flecainide, (S)-Isomer,
Flecainide, 5-HO-N-(6-oxo)-Derivative,
Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer,
Flecatab,
R818,
Tambocor,
Flecainide acetate,
54143-56-5,
Tambocor,
Flecainide (acetate),
FLECAINIDE MONOACETATE,
Flecainide acetate salt,
R 818,
R-818,
EINECS 258-997-5,
MFCD00214290,
MLS000069675,
CHEBI:5091,
N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate,
N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate,
SMR000058451,
EN300-51344,
2,5-Bis-(2,2,2-trifluoroethoxy)-N-(2-piperidinylmethyl)benzamide acetate,
N-(2-Piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate,
n-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate,
Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-, monoacetate,
C19H24F6N2O5,
N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate,
N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate salt,
N-(piperidin-2-ylmethyl)-2,5-bis[(2,2,2-trifluoroethyl)oxy]benzamide acetate,
SR-01000000172,
Flecainidacetat,
Apocard,
Flecainide acetate [USAN:JAN],
Tambocor (TN),
Flecainide acetate [USAN:USP:JAN],
AC1Q2BPX,
DSSTox_CID_626,
Opera_ID_1587,
AC1L24WV,
AC1Q5SY7,
CAS-54143-56-5,
DSSTox_RID_75700,
DSSTox_GSID_20626,
MLS001148177,
MLS002222300,
SCHEMBL121583,
CHEMBL1200822,
DTXSID8020626,
CTK1H0162,
Flecainide acetate (JP17/USP),
RKXNZRPQSOPPRN-UHFFFAOYSA-N,
HMS1570C12,
HMS2097C12,
HMS2231E15,
HMS3259F11,
HMS3267N04,
HMS3369M07,
HMS3676D09,
HMS3714C12,
BCP17825,
Tox21_200208,
GP3700,
AKOS015889993,
API0002710,
CCG-220735,
CS-1400,
LS-7398,
NC00641,
SB19142,
NCGC00093934-01,
NCGC00093934-02,
NCGC00257762-01,
AS-11702,
CC-28437,
CPD000058451,
HY-17429,
SAM002548968,
EU-0100546,
FT-0630667,
D00638,
E-0735,
F 6777,
J10389,
W-5090,
143F565,
SR-01000000172-2,
SR-01000000172-4,
SR-01000000172-5,
SR-01000000172-7,
Flecainide acetate, British Pharmacopoeia (BP) Reference Standard,
Flecainide acetate, European Pharmacopoeia (EP) Reference Standard,
2,5-bis(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)benzamide acetate,
Flecainide acetate, United States Pharmacopeia (USP) Reference Standard,
2-({[2,5-bis(2,2,2-trifluoroethoxy)benzoyl]amino}methyl)piperidinium acetate,
acetic acid; N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide,
acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide,
Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-,monoacetate,
Flecainide for system suitability, European Pharmacopoeia (EP) Reference Standard,
N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; acetic acid,
flecainide,
FLECAINIDEACETATE,
UNII-M8U465Q1WQ,
M8U465Q1WQ,
54143-56-5 (acetate),
CID41022,
C17H20F6N2O3.C2H4O2,
C17-H20-F6-N2-O3.C2-H4-O2,
Benzamide, N-(2-piperidinylmethyl)-2, 5-bis(2,2,2-trifluoroethoxy)-, monoacetate,
54143-55-4,